Post-approval studies (Phase 4)Study completedNCT05684523
What this trial is testing
Feasibility Study on the Use of Redormin®500 on Day-time Cognition
Who this might be right for
Sleep Disorders, Circadian RhythmCognitive Dysfunction
Max Zeller Soehne AG 40